AYURVEDIC MANAGEMENT OF PALMO-PLANTER PSORIASIS: A CASE STUDY
DOI:
https://doi.org/10.70066/jahm.v5i2.335Keywords:
Palmo-planter Psoriasis, Ksudrakushtha , Vipadika ,Internal medication, External therapyAbstract
Palmo-plantar psoriasis (PPP) is a type of Psoriasis limited to the area of the palms and soles. Though only small
body surface area is affected, it is difficult to treat and seriously interferes with the patient’s quality of life. It is
found in 3 - 4% of all psoriasis cases. It is also found in isolation. There is no any direct correlation with any
disease described in Ayurveda but somewhat it can be correlated with Vipadika which is one of the types of the
Ksudrakushtha This is a case of palmo-planter psoriasis. He was taken treatment from different pathies. But due
to frequent recurrence, he preferred Ayurvedic treatment. He was successfully managed with Ayurvedic
treatment including internal medication & some external therapy for three months.
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 YOGESH JAKHOTIYA

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.